Szarkóma: vizsgálatok itt: Mexikó
3 of 4 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
- Where
- México, Mexico City, Monterrey, Oaxaca City, Querétaro
- Életkor
- 18 év and over
- People
- 348 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06345729 · EU 2023-507776-42-00 - 2. fázisFut, nem toborozStudy to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
- Where
- Mexico City, Monterrey, Oaxaca City
- Életkor
- 18 év and over
- People
- 430 worldwide
- Run by
- Pfizer
See details and how to joinNCT04557449 · EU 2024-512120-11-00 - 2. fázisNot yet taking people in MexikóA Study of Propranolol to Treat Kaposi Sarcoma
- Where
- Mexico City
- People
- 25 worldwide
- Run by
- AIDS Malignancy Consortium
See details and how to joinNCT05797662